CMMBVSLABT• 12 Months (Normalized)
CMMB vs LABT (Chemomab Therapeutics Ltd. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-36.5%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
LABT Performance $0.99
-98.86%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CMMB LEADS
+62.36 pts
CMMB outperforming by 62.36 percentage points
CMMBLABT
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CMMB Price | CMMB Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -36.50% | $0.99 | -98.86% | +62.36% |
| Sep 28, 2026 | $1.64 | -37.64% | $1.15 | -98.67% | +61.03% |
| Sep 25, 2026 | $2.16 | -17.87% | $1.67 | -98.07% | +80.20% |
| Sep 24, 2026 | $2.20 | -16.35% | $1.83 | -97.88% | +81.53% |
| Sep 23, 2026 | $2.28 | -13.31% | $1.78 | -97.94% | +84.63% |
| Sep 22, 2026 | $2.51 | -4.56% | $1.99 | -97.70% | +93.14% |
| Sep 21, 2026 | $2.48 | -5.70% | $2.05 | -97.63% | +91.93% |
| Sep 18, 2026 | $2.61 | -0.76% | $1.99 | -97.70% | +96.94% |
| Sep 17, 2026 | $2.80 | +6.46% | $1.86 | -97.85% | +104.31% |
| Sep 16, 2026 | $2.65 | +0.76% | $2.09 | -97.58% | +98.34% |
| Sep 15, 2026 | $2.47 | -6.08% | $2.17 | -97.49% | +91.41% |
| Sep 14, 2026 | $2.45 | -6.84% | $2.12 | -97.55% | +90.71% |
| Sep 11, 2026 | $2.58 | -1.90% | $2.22 | -97.43% | +95.53% |
| Sep 10, 2026 | $2.60 | -1.14% | $2.05 | -97.63% | +96.49% |
| Sep 09, 2026 | $2.69 | +2.28% | $2.32 | -97.32% | +99.60% |
Page 1 of 17